Product How it works Pricing Blog FAQ About Contact
Multilaser

Multilaser (B3: MLAS3) revenue

Multilaser reported revenue of BRL 3,924m for fiscal 2025, 15.8% more than in fiscal 2024 (BRL 3,388m). Since fiscal 2020 its revenue has grown by 27.5%, an average growth of 5.0% a year.

Revenue, in millions of Brazilian reais3,07720204,84720214,38420223,49920233,38820243,9242025

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025BRL 3,924m+15.8%BRL 106.5m2.7%
2024BRL 3,388m−3.2%−BRL 20.5m−0.6%
2023BRL 3,499m−20.2%−BRL 726.4m−20.8%
2022BRL 4,384m−9.5%BRL 185.3m4.2%
2021BRL 4,847m+57.5%BRL 778.5m16.1%
2020BRL 3,077m—BRL 524.8m17.1%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of Brazilian reais, except per-share amounts.

Questions about the revenue of Multilaser

How much revenue did Multilaser make in fiscal 2025?
Multilaser reported revenue of BRL 3,924m for fiscal 2025, compared with BRL 3,388m in fiscal 2024.
How much has the revenue of Multilaser grown?
Between fiscal 2020 and fiscal 2025 it went from BRL 3,077m to BRL 3,924m: 27.5% more, an average growth of 5.0% a year.
What was the best year for revenue at Multilaser?
Of its last 6 fiscal years, fiscal 2021, with BRL 4,847m.
Where do the figures for Multilaser come from?
From the annual financial statements (DFP) that Multilaser files with the CVM, the Brazilian securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual financial statements (DFP) that Multilaser files with the CVM, the Brazilian securities regulator. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Multilaser: the Multilaser page · annual accounts · net income.

More companies from Brazil and the rest of the region: Latin American stocks.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.